RTW Investments’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$235M	Buy	3,346,025 +10,705	+0.3%	+$748K	2.34%	12
2025 Q4	$273M	Buy	3,335,320 +157,884	+5%	+$11.8M	2.74%	8
2025 Q3	$189M	Buy	3,177,436 +65,756	+2%	+$3.24M	2.33%	13
2025 Q2	$126M	Sell	3,111,680 -204,352	-6%	-$9.2M	1.8%	20
2025 Q1	$170M	Buy	3,316,032 +79,483	+2%	+$3.93M	2.61%	15
2024 Q4	$179M	Sell	3,236,549 -175,937	-5%	-$7.99M	2.71%	14
2024 Q3	$112M	Hold	3,412,486	–	–	1.62%	26
2024 Q2	$92.8M	Buy	3,412,486 +140,145	+4%	+$4.71M	1.44%	25
2024 Q1	$119M	Buy	3,272,341 +120,000	+4%	+$3.53M	1.76%	22
2023 Q4	$63.8M	Buy	3,152,341 +271,640	+9%	+$4.54M	1%	28
2023 Q3	$51.2M	Buy	2,880,701 +332,576	+13%	+$5.89M	1.08%	24
2023 Q2	$46M	Hold	2,548,125	–	–	0.88%	28
2023 Q1	$32M	Hold	2,548,125	–	–	0.67%	30
2022 Q4	$37.4M	Buy	2,548,125 +524,946	+26%	+$8.69M	0.76%	30
2022 Q3	$34.6M	Buy	2,023,179 +9,578	+0.5%	+$152K	0.8%	35
2022 Q2	$29.4M	Hold	2,013,601	–	–	0.76%	34
2022 Q1	$33.9M	Hold	2,013,601	–	–	0.7%	41
2021 Q4	$45.3M	Hold	2,013,601	–	–	0.66%	48
2021 Q3	$43.4M	Hold	2,013,601	–	–	0.65%	43
2021 Q2	$58.4M	Sell	2,013,601 -450,000	-18%	-$14.1M	0.88%	32
2021 Q1	$79.1M	Hold	2,463,601	–	–	1.23%	29
2020 Q4	$99M	Buy	+2,463,601	New	+$70.2M	1.66%	17